Functional assays demonstrated that SOX2 silencing inhibited proliferation of glioma cells, whereas increased SOX2 expression enhanced proliferation of glioma cells by colony formation assay (Figure 9F), CCK-8 assay (Figure 9G), and EdU assay (Figure 9H). The gene discussed is SOX2; the disease is glioma.